288 related articles for article (PubMed ID: 29554088)
41. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
Li H; Zhao JL; Zhang YM; Han SX
Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
[TBL] [Abstract][Full Text] [Related]
43. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
Lin H; Zheng C; Li J; Yang C; Hu L
Int Immunopharmacol; 2014 Dec; 23(2):642-8. PubMed ID: 25466273
[TBL] [Abstract][Full Text] [Related]
44. Expression of insulin-like growth factor 2 receptor in corneal keratocytes during differentiation and in response to wound healing.
Bohnsack RN; Warejcka DJ; Wang L; Gillespie SR; Bernstein AM; Twining SS; Dahms NM
Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7697-708. PubMed ID: 25358730
[TBL] [Abstract][Full Text] [Related]
45. The role and mechanism of K
Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
47. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
Huang C; Pollock CA; Chen XM
PLoS One; 2014; 9(4):e95173. PubMed ID: 24733189
[TBL] [Abstract][Full Text] [Related]
48. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to alkalinization-induced vascular calcification in vitro.
Bai Y; Xu J; Yang S; Zhang H; He L; Zhou W; Cheng M; Zhang S
J Clin Lab Anal; 2021 Aug; 35(8):e23854. PubMed ID: 34313357
[TBL] [Abstract][Full Text] [Related]
49. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
[TBL] [Abstract][Full Text] [Related]
50. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
Toyama K; Wulff H; Chandy KG; Azam P; Raman G; Saito T; Fujiwara Y; Mattson DL; Das S; Melvin JE; Pratt PF; Hatoum OA; Gutterman DD; Harder DR; Miura H
J Clin Invest; 2008 Sep; 118(9):3025-37. PubMed ID: 18688283
[TBL] [Abstract][Full Text] [Related]
51. K
Lu R; Flauaus C; Kennel L; Petersen J; Drees O; Kallenborn-Gerhardt W; Ruth P; Lukowski R; Schmidtko A
Neuropharmacology; 2017 Oct; 125():386-395. PubMed ID: 28823609
[TBL] [Abstract][Full Text] [Related]
52. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
53. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Grimaldi A; D'Alessandro G; Golia MT; Grössinger EM; Di Angelantonio S; Ragozzino D; Santoro A; Esposito V; Wulff H; Catalano M; Limatola C
Cell Death Dis; 2016 Apr; 7(4):e2174. PubMed ID: 27054329
[TBL] [Abstract][Full Text] [Related]
54. Involvement of Ca
Guo S; Shen Y; He G; Wang T; Xu D; Wen F
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28679649
[TBL] [Abstract][Full Text] [Related]
55. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.
Girault A; Chebli J; Privé A; Trinh NT; Maillé E; Grygorczyk R; Brochiero E
Respir Res; 2015 Sep; 16(1):100. PubMed ID: 26335442
[TBL] [Abstract][Full Text] [Related]
56. The role of KCa3.1 channels in cardiac fibrosis induced by pressure overload in rats.
Zhao LM; Wang LP; Wang HF; Ma XZ; Zhou DX; Deng XL
Pflugers Arch; 2015 Nov; 467(11):2275-85. PubMed ID: 25715999
[TBL] [Abstract][Full Text] [Related]
57. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
58. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
Chen YJ; Lam J; Gregory CR; Schrepfer S; Wulff H
PLoS One; 2013; 8(11):e81006. PubMed ID: 24312257
[TBL] [Abstract][Full Text] [Related]
59. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
60. Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis.
Chen WS; Cao Z; Leffler H; Nilsson UJ; Panjwani N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):9-20. PubMed ID: 28055102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
